OMCL
Omnicell Inc
NASDAQ: OMCL · HEALTHCARE · HEALTH INFORMATION SERVICES
$41.42
-3.90% today
Updated 2026-04-30
Market cap
$2.07B
P/E ratio
103.43
P/S ratio
1.69x
EPS (TTM)
$0.44
Dividend yield
—
52W range
$23 – $55
Volume
0.6M
Omnicell Inc (OMCL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1.67%
Operating margin
5.44%
ROE
1.63%
ROA
1.21%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $154.71M | $10.37M | 55.28% | 5.98% | 6.70% |
| 2007 | $213.08M | $43.30M | 53.18% | 8.55% | 20.32% |
| 2008 | $251.87M | $12.72M | 51.07% | 6.88% | 5.05% |
| 2009 | $213.46M | $444000.00 | 49.29% | 0.31% | 0.21% |
| 2010 | $222.41M | $4.89M | 53.02% | 4.28% | 2.20% |
| 2011 | $245.53M | $10.39M | 55.30% | 6.61% | 4.23% |
| 2012 | $314.03M | $16.16M | 54.31% | 8.62% | 5.15% |
| 2013 | $380.58M | $23.98M | 53.44% | 9.27% | 6.30% |
| 2014 | $440.90M | $30.52M | 53.04% | 11.25% | 6.92% |
| 2015 | $484.56M | $30.76M | 51.17% | 10.04% | 6.35% |
| 2016 | $692.62M | $603000.00 | 45.31% | 0.94% | 0.09% |
| 2017 | $716.16M | $20.61M | 44.97% | 0.80% | 2.88% |
| 2018 | $787.31M | $37.73M | 47.29% | 5.64% | 4.79% |
| 2019 | $897.03M | $61.34M | 48.71% | 8.73% | 6.84% |
| 2020 | $892.21M | $32.19M | 46.32% | 3.98% | 3.61% |
| 2021 | $1.13B | $77.85M | 49.00% | 7.91% | 6.88% |
| 2022 | $1.30B | $5.65M | 45.45% | -0.18% | 0.44% |
| 2023 | $1.15B | $-20.37M | 43.31% | -3.04% | -1.78% |
| 2024 | $1.11B | $12.53M | 42.35% | 0.03% | 1.13% |
| 2025 | $1.18B | $2.05M | 42.49% | 0.44% | 0.17% |